₹635.65
−7.83%NSE close, 16 Nov 2026
+12.49%
Solara Active Pharma Sciences is a small cap company, listed on NSE under the symbol SOLARA. At ₹635.65 a share, the market values the whole company at ₹3,056 crore.
In FY26, it reported sales of ₹1,369 crore and a net loss of ₹7 crore, an operating margin of 13.6%. Over the last three years, sales fell 1.8% a year.
The market values the company at 82.7 times its profit over the last twelve months and 2.13 times its book value; its return on equity is 2.6% and its borrowings are 0.40 times its equity.
Promoters hold 41.93% of the shares, and have pledged 52.0% of their holding. Foreign institutions hold 10.71%, and domestic institutions, mutual funds among them, 3.89%.
Over the past year the share price has risen 13.0%, and it is 17.9% below its 52-week high.
₹ crore. Consolidated figures.
Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended September 30, 2026
Final Reminder-cum-Forfeiture Notice for the payment of outstanding call money to the holders of partly paid-up equity shares of the Company.
Monitoring Agency Report for the quarter ended September 30, 2026
Audio recordings of Q2 FY27 earnings call conducted on October 16, 2026, for the quarter ended September 30, 2026
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 249 | 299 | 363 | 347 | 300 | 273 | 319 | 314 | 349 | 387 | 382 | 417 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 410 | 290 | 322 | 286 | 243 | 228 | 262 | 279 | 312 | 330 | 320 | 341 |
| Operating profit | −162 | 9.8 | 41.9 | 61.3 | 57.7 | 45.4 | 57.0 | 34.7 | 37.3 | 57.7 | 62.0 | 76.8 |
| Operating margin | -65.0% | 3.3% | 11.5% | 17.7% | 19.2% | 16.6% | 17.9% | 11.1% | 10.7% | 14.9% | 16.2% | 18.4% |
| Other income | 0.5 | 1.7 | 0.6 | 0.3 | 1.5 | 6.0 | 1.0 | 0.5 | 0 | 4.7 | 2.7 | 0.5 |
| Interest | 25.4 | 30.7 | 30.9 | 28.3 | 26.5 | 29.1 | 23.9 | 20.8 | 22.5 | 27.6 | 21.6 | 17.8 |
| Depreciation | 26.0 | 25.3 | 25.1 | 25.3 | 24.5 | 24.3 | 23.6 | 24.5 | 25.6 | 26.0 | 26.7 | 26.6 |
| Profit before tax | −275 | −167 | −13.5 | 8.0 | 8.1 | −2.1 | 10.5 | −10.1 | −17.4 | 9.6 | 16.3 | 28.5 |
| Tax | 0 | 88.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | −275 | −255 | −13.5 | 8.0 | 8.1 | −2.1 | 10.5 | −10.1 | −17.4 | 9.6 | 16.3 | 28.5 |
| EPS (₹) | -76.49 | -70.93 | -3.50 | 2.54 | 2.03 | -0.93 | 2.46 | -2.36 | -3.98 | 2.20 | 3.52 | 5.92 |
₹ crore, financial years to March.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,387 | 1,322 | 1,617 | 1,268 | 1,444 | 1,326 | 1,284 | 1,369 |
| Expenses | 1,166 | 1,062 | 1,231 | 1,188 | 1,310 | 1,421 | 1,077 | 1,182 |
| Operating profit | 221 | 259 | 386 | 80.0 | 134 | −95.2 | 206 | 187 |
| Operating margin | 15.9% | 19.6% | 23.9% | 6.3% | 9.3% | -7.2% | 16.1% | 13.6% |
| Other income | 12.4 | 27.5 | 28.8 | 20.0 | 22.6 | 5.4 | 8.3 | 6.2 |
| Interest | 82.4 | 77.9 | 84.5 | 75.3 | 90.1 | 105 | 115 | 94.8 |
| Depreciation | 83.1 | 94.2 | 109 | 112 | 111 | 103 | 99.3 | 99.7 |
| Profit before tax | 67.7 | 115 | 222 | −91.1 | −44.8 | −488 | 0.5 | −7.4 |
| Tax | 0.6 | 0.4 | 0.2 | −32.8 | −22.6 | 78.5 | 0 | 0 |
| Net profit | 59.4 | 111 | 221 | −58.2 | −22.2 | −567 | 0.5 | −7.4 |
| EPS (₹) | 21.77 | 44.29 | 69.00 | -16.18 | -6.16 | -157.62 | 0.14 | -1.68 |
₹ crore, at each year's end and the latest half year.
| Line | FY23 | FY24 | FY25 | FY26 | Sep 2026 |
|---|---|---|---|---|---|
| Shareholders’ equity | 1,500 | 934 | 1,094 | 1,253 | 1,436 |
| Borrowings | 1,001 | 1,000 | 776 | 665 | 570 |
| Total liabilities | 1,397 | 1,414 | 1,135 | 1,077 | 1,015 |
| Fixed assets | 921 | 858 | 739 | 793 | 765 |
| Investments | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 |
| Cash and equivalents | 8.7 | 8.4 | 4.0 | 4.5 | 24.1 |
| Total assets | 2,899 | 2,351 | 2,232 | 2,333 | 2,454 |
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | −242 | 213 | 153 | 63.4 |
| From investing | −243 | −36.8 | −98.8 | −46.0 |
| From financing | 334 | −180 | −53.6 | 2.3 |
| Spent on fixed assets | −209 | −39.9 | −52.8 | −54.8 |
| Free cash flow | −451 | 173 | 100 | 8.5 |
Margins, returns, debt, tax and cash.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Net margin | 4.3% | 8.4% | 13.7% | -4.6% | -1.5% | -42.8% | 0.0% | -0.5% |
| Operating margin | 15.9% | 19.6% | 23.9% | 6.3% | 9.3% | -7.2% | 16.1% | 13.6% |
| Return on equity | – | – | – | – | -1.5% | -60.8% | 0.0% | -0.6% |
| Return on capital employed | – | – | – | – | 1.8% | -19.8% | 6.2% | 4.6% |
| Return on assets | – | – | – | – | -0.8% | -24.1% | 0.0% | -0.3% |
| Debt to equity | – | – | – | – | 0.67 | 1.07 | 0.71 | 0.53 |
| Interest coverage | 1.80 | 2.50 | 3.60 | -0.20 | 0.50 | -3.60 | 1.00 | 0.90 |
| Debt to assets | – | – | – | – | 0.35 | 0.43 | 0.35 | 0.28 |
| Current ratio | – | – | – | – | 1.08 | 0.63 | 0.77 | 0.96 |
| Quick ratio | – | – | – | – | 0.57 | 0.34 | 0.44 | 0.60 |
| Cash ratio | – | – | – | – | 0.01 | 0.01 | 0.00 | 0.01 |
| Asset turnover | – | – | – | – | 0.50 | 0.56 | 0.58 | 0.59 |
| Fixed asset turnover | – | – | – | – | 1.57 | 1.55 | 1.74 | 1.73 |
| Inventory turnover | – | – | – | – | – | 2.20 | 2.00 | 2.20 |
| Receivables turnover | – | – | – | – | 2.70 | 3.80 | 3.90 | 3.10 |
| Gross margin | – | – | – | – | – | 39.3% | 51.2% | 50.0% |
| Cash from operations to profit | – | – | – | – | – | – | 39,411.0% | – |
| Effective tax rate | 0.9% | 0.3% | 0.1% | – | – | – | 0.0% | – |
Grant of 470000 Options under Solara Employee Stock Option Plan 2024.
Solara s Q2 FY27 revenue grows 33% to INR 4,178 Mn and EBITDA more than doubles to INR 769 Mn, its best quarter in five years
Allotment of 8,300 equity shares pursuant to exercise of ESOP options.
Inter alia, to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026, along with the Limited Review Report for the said period.
The Schedule of Investors/Analysts call to be held on Friday, October 16, 2026 at 4.00 PM IST to discuss the Company's unaudited financial results for the quarter and half year ended September 30, 2026.
The ESG rating received from Crisil ESG Ratings & Analytics Limited.
Update on approval of Final Reminder cum Forfeiture Notice for payment of outstanding call money
Intimation to furnish valid PAN, KYC details and Nomination by shareholders holding physical shares
The Voting Results and the Scrutinizer's report of the Ninth Annual General Meeting
Proceedings of Ninth Annual General Meeting held on September 18, 2026